Results
Syncom Formulations Q1 PAT Surges 58% YoY
Syncom Formulations reported Q1 FY27 consolidated PAT of ₹24.85 crore, up 58% YoY, on revenue growth of 8%.
The Board recommended a final dividend of ₹0.10 per share for FY26, subject to shareholder a